Transition and Separation AgreementTransition and Separation Agreement • April 6th, 2021 • Precision Biosciences Inc • Biological products, (no disgnostic substances) • North Carolina
This Transition and Separation Agreement (“Agreement”) is made as of April 1, 2021 (the “Notice Date”), by and between Precision BioSciences, Inc. (the “Company”) and Matthew Kane (the “Executive”) (collectively referred to as the “parties” or individually referred to as a “party”). Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Employment Agreement (as defined below).
